176 related articles for article (PubMed ID: 23065847)
21. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells.
Abedi H; Zachary I
J Biol Chem; 1997 Jun; 272(24):15442-51. PubMed ID: 9182576
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-I-stimulated lamellipodial advance.
Leventhal PS; Shelden EA; Kim B; Feldman EL
J Biol Chem; 1997 Feb; 272(8):5214-8. PubMed ID: 9030591
[TBL] [Abstract][Full Text] [Related]
24. The indolinone MAZ51 induces cell rounding and G2/M cell cycle arrest in glioma cells without the inhibition of VEGFR-3 phosphorylation: involvement of the RhoA and Akt/GSK3β signaling pathways.
Park JH; Shin YJ; Riew TR; Lee MY
PLoS One; 2014; 9(9):e109055. PubMed ID: 25268128
[TBL] [Abstract][Full Text] [Related]
25. The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts.
Rössler J; Monnet Y; Farace F; Opolon P; Daudigeos-Dubus E; Bourredjem A; Vassal G; Geoerger B
Int J Cancer; 2011 Jun; 128(11):2748-58. PubMed ID: 20715103
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase.
Avraham HK; Lee TH; Koh Y; Kim TA; Jiang S; Sussman M; Samarel AM; Avraham S
J Biol Chem; 2003 Sep; 278(38):36661-8. PubMed ID: 12844492
[TBL] [Abstract][Full Text] [Related]
27. Reactive oxygen species increased focal adhesion kinase production in pulmonary microvascular endothelial cells.
Yang S; Yip R; Polena S; Sharma M; Rao S; Griciene P; Gintautas J; Jerome H
Proc West Pharmacol Soc; 2004; 47():54-6. PubMed ID: 15633612
[TBL] [Abstract][Full Text] [Related]
28. Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways.
Salameh A; Galvagni F; Bardelli M; Bussolino F; Oliviero S
Blood; 2005 Nov; 106(10):3423-31. PubMed ID: 16076871
[TBL] [Abstract][Full Text] [Related]
29. LKB1 represses focal adhesion kinase (FAK) signaling via a FAK-LKB1 complex to regulate FAK site maturation and directional persistence.
Kline ER; Shupe J; Gilbert-Ross M; Zhou W; Marcus AI
J Biol Chem; 2013 Jun; 288(24):17663-74. PubMed ID: 23637231
[TBL] [Abstract][Full Text] [Related]
30. N-MYC regulates focal adhesion kinase expression in human neuroblastoma.
Beierle EA; Trujillo A; Nagaram A; Kurenova EV; Finch R; Ma X; Vella J; Cance WG; Golubovskaya VM
J Biol Chem; 2007 Apr; 282(17):12503-16. PubMed ID: 17327229
[TBL] [Abstract][Full Text] [Related]
31. A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.
Kurenova E; Ucar D; Liao J; Yemma M; Gogate P; Bshara W; Sunar U; Seshadri M; Hochwald SN; Cance WG
Cell Cycle; 2014; 13(16):2542-53. PubMed ID: 25486195
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.
Aboubakar Nana F; Lecocq M; Ladjemi MZ; Detry B; Dupasquier S; Feron O; Massion PP; Sibille Y; Pilette C; Ocak S
Mol Cancer Ther; 2019 Jan; 18(1):17-27. PubMed ID: 30352800
[TBL] [Abstract][Full Text] [Related]
33. TAE226 inhibits human neuroblastoma cell survival.
Beierle EA; Trujillo A; Nagaram A; Golubovskaya VM; Cance WG; Kurenova EV
Cancer Invest; 2008 Mar; 26(2):145-51. PubMed ID: 18259944
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.
Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Tumour Biol; 2013 Aug; 34(4):2109-17. PubMed ID: 23580180
[TBL] [Abstract][Full Text] [Related]
35. The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration.
Holmqvist K; Cross MJ; Rolny C; Hägerkvist R; Rahimi N; Matsumoto T; Claesson-Welsh L; Welsh M
J Biol Chem; 2004 May; 279(21):22267-75. PubMed ID: 15026417
[TBL] [Abstract][Full Text] [Related]
36. Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53.
Golubovskaya VM; Finch R; Cance WG
J Biol Chem; 2005 Jul; 280(26):25008-21. PubMed ID: 15855171
[TBL] [Abstract][Full Text] [Related]
37. A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt.
Mehta RR; Yamada T; Taylor BN; Christov K; King ML; Majumdar D; Lekmine F; Tiruppathi C; Shilkaitis A; Bratescu L; Green A; Beattie CW; Das Gupta TK
Angiogenesis; 2011 Sep; 14(3):355-69. PubMed ID: 21667138
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo.
Kurenova EV; Hunt DL; He D; Fu AD; Massoll NA; Golubovskaya VM; Garces CA; Cance WG
Cell Cycle; 2009 Jul; 8(14):2266-80. PubMed ID: 19556880
[TBL] [Abstract][Full Text] [Related]
39. MYCN, neuroblastoma and focal adhesion kinase (FAK).
Beierle EA
Front Biosci (Elite Ed); 2011 Jan; 3(2):421-33. PubMed ID: 21196322
[TBL] [Abstract][Full Text] [Related]
40. Astrocytoma adhesion to extracellular matrix: functional significance of integrin and focal adhesion kinase expression.
Rutka JT; Muller M; Hubbard SL; Forsdike J; Dirks PB; Jung S; Tsugu A; Ivanchuk S; Costello P; Mondal S; Ackerley C; Becker LE
J Neuropathol Exp Neurol; 1999 Feb; 58(2):198-209. PubMed ID: 10029102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]